The Director General of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail or the applicant for marketing authorisation may refer the matter to the European Medicines Agency with a view to the application of the Community arbitration procedure provided for in Articles 36 to 38 of Directive 2001/82/EC of the European Parliament and of the Council when divergent decisions have been taken by Member States of the European Union concerning the authorisation, variation, suspension or withdrawal of a veterinary medicinal product.